Sulforaphane in broccoli sprouts found to improve glucose levels in diabetics

June 15, 2017 by Bob Yirka, Medical Xpress report
broccoli
broccoli

A team of researchers from Sweden, the U.S. and Switzerland has found that treating rat liver cells with a compound called sulforaphane, which is found in cruciferous vegetables, reduced production of glucose. In their paper published in Science Translational Medicine, the group outlines the methods they used to isolate the compound and what they found when testing it with liver cells and in human patients.

Type 2 diabetes has been in the news a lot in the past several years due to its ties to the obesity epidemic in several countries, particularly the U.S. Prior research has shown that it is a condition in which the body mishandles glucose—cells fail to use insulin properly, leading to higher , which can cause a wide variety of health problems. Current treatment includes modifying the diet and taking drugs such as metformin. But because the drugs used to treat diabetes can cause other problems, such as , researchers continue to look for alternatives. In this new effort, the researchers sought to find a compound that could alleviate symptoms in a more natural way. They created a for the disease based on 50 genes that have previously been linked to the disorder and fed the results into a database, which used the genetic signature to look for specifically related to gene expression in liver cells—sulforaphane showed the strongest known effects.

The researchers then cultured from rats with type 2 diabetes and applied sulforaphane to see what would happen—doing so caused the cells to produce less glucose. Optimistic about their results, the researchers next tested the compound on 97 obese human volunteers with type 2 diabetes over a 12-week period—this was possible because sulforaphane is a compound naturally occurring in such as broccoli sprouts. The researchers report that those given the compound showed a significant reduction in glucose levels (while fasting).

The researchers acknowledge that their results are preliminary and that more testing of the compound will be needed to prove that the compound or simply eating the right vegetables might someday replace drugs used to treat type 2 diabetes. They note also that their technique for discovering the compound's usefulness in treating the disease could very well be applied to other diseases.

Explore further: Vegetable compound could become ingredient to treating leukemia

More information: Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aah4477

Related Stories

Vegetable compound could become ingredient to treating leukemia

December 12, 2012
It looks like your mother was on to something when she said, "Eat your vegetables!" A concentrated form of a compound called sulforaphane found in broccoli and other cruciferous vegetables has been shown to reduce the number ...

Scientists discover new class of anti-diabetes compounds that reduce liver glucose production

March 27, 2017
Scientists may have found a new tool for studying—and maybe even treating—Type 2 diabetes, the form of diabetes considered responsible for close to 95 percent of cases in the United States.

New strategy to lower blood sugar may help in diabetes treatment

September 3, 2015
Some treatments for type 2 diabetes make the body more sensitive to insulin, the hormone that lowers blood sugar. But new research at Washington University School of Medicine in St. Louis suggests a different strategy: slowing ...

A dual-functional GLP-1 analogue may improve insulin sensitivity and help fight diabetes

May 11, 2017
According to research published online in The FASEB Journal, scientists have discovered a dual peptide called "PGLP-1" that promotes insulin secretion and inhibits gluconeogenesis (a metabolic process that produces glucose). ...

Exercise mimic molecule may help treat diabetes and obesity

July 27, 2015
Scientists from the University of Southampton have developed a molecule that acts as an exercise mimic, which could potentially help treat type 2 diabetes and obesity.

Recommended for you

Switching to certain antidiabetic drugs linked to increased risk of major complications

July 18, 2018
For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds a study in The BMJ today.

Researchers cure type 2 diabetes and obesity in mice using gene therapy

July 10, 2018
A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy

July 9, 2018
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent ...

New targets found to reduce blood vessel damage in diabetes

July 9, 2018
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature.

Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes

July 9, 2018
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an ...

Abnormal branched-chain amino acid breakdown may raise diabetes risk

July 5, 2018
In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus (GDM), a temporary form of diabetes in which hormonal changes disrupt insulin function. Although GDM is often symptomless and subsides ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.